Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP9802.RAlmX9iQH-nV3qLGged3oEGLSKUuo_tmikq_0_ig6Taxw130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP9802.RAlmX9iQH-nV3qLGged3oEGLSKUuo_tmikq_0_ig6Taxw130_assertion type Assertion NP9802.RAlmX9iQH-nV3qLGged3oEGLSKUuo_tmikq_0_ig6Taxw130_head.
- NP9802.RAlmX9iQH-nV3qLGged3oEGLSKUuo_tmikq_0_ig6Taxw130_assertion wasGeneratedBy ECO_0000218 NP9802.RAlmX9iQH-nV3qLGged3oEGLSKUuo_tmikq_0_ig6Taxw130_provenance.
- NP9802.RAlmX9iQH-nV3qLGged3oEGLSKUuo_tmikq_0_ig6Taxw130_assertion wasDerivedFrom ctd_human-20150221 NP9802.RAlmX9iQH-nV3qLGged3oEGLSKUuo_tmikq_0_ig6Taxw130_provenance.
- NP9802.RAlmX9iQH-nV3qLGged3oEGLSKUuo_tmikq_0_ig6Taxw130_assertion SIO_000772 17043644 NP9802.RAlmX9iQH-nV3qLGged3oEGLSKUuo_tmikq_0_ig6Taxw130_provenance.
- NP9802.RAlmX9iQH-nV3qLGged3oEGLSKUuo_tmikq_0_ig6Taxw130_assertion evidence source_evidence_curated NP9802.RAlmX9iQH-nV3qLGged3oEGLSKUuo_tmikq_0_ig6Taxw130_provenance.
- NP9802.RAlmX9iQH-nV3qLGged3oEGLSKUuo_tmikq_0_ig6Taxw130_assertion description "[Pharmacologic inhibition of epigenetic modifications, coupled with gene expression profiling, reveals novel targets of aberrant DNA methylation and histone deacetylation in lung cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP9802.RAlmX9iQH-nV3qLGged3oEGLSKUuo_tmikq_0_ig6Taxw130_provenance.